From small molecule to cellular immunotherapy: therapeutic approaches for leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Dissertation, 2022
- Schlagwort
-
Leukämie
Krebs
Akute myeloische Leukämie
Immuntherapie
Blutstammzelle
T-Lymphozyt
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2022
- Urheber
- Beteiligte Personen und Organisationen
-
Subklewe, Marion
- DOI
-
10.5282/edoc.31191
- URN
-
urn:nbn:de:bvb:19-311914
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rohrbacher, Lisa
- Subklewe, Marion
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2022
Ähnliche Objekte (12)
Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia
Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma
CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia
Small-Molecule Targets in Tumor Immunotherapy
Cellular immunotherapy for refractory hematological malignancies
Wilms' tumor 1 (WT1) specific immune cells as a tool for cellular immunotherapy in acute myeloid leukemia
Cellular based immunotherapy for primary liver cancer
Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation
Recent developments in immunotherapy of acute myeloid leukemia
Cellular immunotherapy in patients with advanced Ewing sarcoma
Cellular fate of a plant virus immunotherapy candidate
T cell receptor-engineered T cells for leukemia immunotherapy
Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia
Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma
CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia
Small-Molecule Targets in Tumor Immunotherapy
Cellular immunotherapy for refractory hematological malignancies
Wilms' tumor 1 (WT1) specific immune cells as a tool for cellular immunotherapy in acute myeloid leukemia
Cellular based immunotherapy for primary liver cancer
Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation
Recent developments in immunotherapy of acute myeloid leukemia
Cellular immunotherapy in patients with advanced Ewing sarcoma
Cellular fate of a plant virus immunotherapy candidate
T cell receptor-engineered T cells for leukemia immunotherapy
Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia
Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma
CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia
Small-Molecule Targets in Tumor Immunotherapy
Cellular immunotherapy for refractory hematological malignancies
Wilms' tumor 1 (WT1) specific immune cells as a tool for cellular immunotherapy in acute myeloid leukemia
Cellular based immunotherapy for primary liver cancer
Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation
Recent developments in immunotherapy of acute myeloid leukemia
Cellular immunotherapy in patients with advanced Ewing sarcoma
Cellular fate of a plant virus immunotherapy candidate